Gastrointestinal Bleeding refers to blood loss that occurs within the digestive organs. High prevalence of upper gastrointestinal bleeding, rise in applications of endoscopic hemostasis, and growing geriatric population are the main factors that are boosting the growth of the gastrointestinal bleeding treatment market. According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. The increase in the number of geriatrics leads to consequences, such as a greater incidence of life-threatening diseases which sometimes related to gastrointestinal bleeding, further requiring treatment from hospitals. This boosts the growth of the studied market.
However, the dearth of skilled labor is expected to restrain the growth of the global market in the forecast period.
Scope of the Report
As per the scope of the report, Gastrointestinal Bleeding refers to any form of hemorrhage or blood loss that occurs within the digestive organs like the esophagus, stomach, small intestine including the duodenum, rectum, etc. It includes all forms of bleeding of the gastrointestinal tract, from the mouth to the rectum.
Key Market Trends
Upper GI Tract Segment is Expected to Register a Good Growth Over the Forecast Period
By GI tract division, the market has been segmented into Upper GI Tract, and Lower GI Tract. The upper GI tract accounted for major share in the gastrointestinal bleeding treatment market and this trend is likely to continue during the forecast period. A peptic ulcer is one of the most common causes of upper GI tract bleeding and is known to have increased prevalence owing to an increase in H. pylori infection. Irrespective of any region, the peptic ulcer cases are quite common because of unhealthy diet habits by many people. As per a recent article of 2019, published in Medscape, peptic ulcer disease affects approximately 4.6 million people annually in the United States with an estimated 10% of the US population having evidence of a duodenal ulcer at some time. Other conditions also include esophageal varices, gastritis, and cancer of the esophagus or stomach. In addition, the growing geriatric population and rise in applications of endoscopic hemostasis also contribute to the growth of the demand for treatments related to upper gastrointestinal bleedings.
North America is expected to lead the Gastrointestinal Bleeding Treatment Market
North America leads the market owing to the upsurge in the demand for advanced treatment options, and the prevalence of upper gastrointestinal bleeding. According to The National Institute of Diabetes and Digestive and Kidney Diseases, every year, upper GI bleeding accounts for about 100,000 hospitalizations in the United States. There is a large section of the population in the adult age group across many states, which have unhealthy diet habits leading to several problems associated with the upper and lower gastrointestinal tract, which may lead to bleeding if not diagnosed properly. Thus, a growing burden of such patients is being observed approaching the hospitals for better treatment particularly during the advanced stage of the disease. This drives the market of the gastrointestinal bleeding treatment
Europe and the Asia Pacific are followed next after North America owing to the presence of a diversified patient pool, and emerging economies in these regions, thus driving this market.
The major players in the gastrointestinal bleeding treatment market include Boston Scientific Corporation, CONMED Corporation, Cook Group, ERBE Elektromedizin GmbH, Olympus Corporation, Ovesco Endoscopy AG, STERIS PLC, and US Medical Innovations are providing these products across the globe.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client's requirements
- 3 months of analyst support
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of upper gastrointestinal bleeding
4.2.2 Technology Advancement Related to Gastrointestinal Diseases Treatment
4.3 Market Restraints
4.3.1 Dearth of Skilled Labor
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Endoscopic Mechanical Devices
5.1.2 Endoscopic Thermal Devices
5.2 By GI Tract Division
5.2.1 Upper GI Tract
5.2.2 Lower GI Tract
5.3 By End User
5.3.2 Ambulatory Surgical Centres
5.4.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
5.4.3 Asia Pacific
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.4.4 Middle East and Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East and Africa
5.4.5 South America
126.96.36.199 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 CONMED Corporation
6.1.3 Cook Group
6.1.4 ERBE Elektromedizin GmbH
6.1.5 Olympus Corporation
6.1.6 Ovesco Endoscopy AG
6.1.7 STERIS PLC
6.1.8 US Medical Innovations
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.